In order to effectively evaluate any new business development opportunities and ensure that the true value of a transaction has been realized, while forecasting the probability of both development and commercial success, life science companies need to ensure the right internal experts are involved in the evaluation process. This calls for the development and continuous improvement of a formal process that will allow organizations to efficiently and effectively evaluate, negotiate, manage, and close a transaction. The 2nd BDandL Summit serves as an open forum for cross-functional business development teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements and M&A deals. URLs: Tickets https://go.evvnt.com/535236-0?pid=5569 Brochure https://go.evvnt.com/535236-3?pid=5569 Prices:Advanced Early Bird Pricing - Register by December 1, 2019: USD 1695.00,Early Bird Prcing - Register by January 24,2020: USD 1895.00,Standard Pricing: USD 2095.00. Speakers: Jennifer Leeds , Karah Parschauer , Chris Slavinsky, Chris Haskell, Kevin Lynch, Philip Gutry, Jay Parrish, Sheldon Koenig, Antoun Nabhan, Mark Kafka, Angele Maki, Linus Lin. Time: 8:00 am to 5:00 pm. Venue details: Hyatt Centric Fishermans Wharf San Francisco, 555 North Point Street, San Francisco, California, 94133, United States.